Trade GALENICA N - GALE CFD

Galenica AG Company profile

About Galenica AG

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Galenica AG revenues increased 10% to SF3.83B. Net income applicable to common stockholders decreased 3% to SF167.7M. Revenues reflect Products & Care segment increase of 14% to SF1.83B, Logistics & IT segment increase of 7% to SF2B, Other countries segment increase of 13% to SF30.6M. Net income was offset by Personnel costs increase of 17% to SF518.9M (expense).